AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75N93025C00029VIVID BIOINNOVATIONS, PBC
Overview
Award facts
- Net obligations
- $595.34K
- $595,337of $2.57M potential value
- Outlays (paid to date)
- $99.22K
- $99.22K paid of $595.34K obligated$99,224
- Period of performance
- Sep 1, 2025 to Aug 31, 2027
- Ends in 9 months
- Modifications
- 0
- Latest action Aug 28, 2025
- Contract type
- Definitive contract
- PIID 75N93025C00029
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
MULTIPLEXED NUCLEIC ACID SELF-TEST FOR REPRODUCIBLE AND SENSITIVE HIV DETECTION
Dates and value
- Award date
- Signed on Aug 28, 2025
- Potential end of performance
- Aug 30, 2029
- Current value
- $595,337Base and exercised options
- Potential value (if all options are exercised)
- $2,566,049
Obligations by fiscal year of action
- FY2025: $595,337
Total across 1 fiscal year: $595,337
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 28, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationSAN FRANCISCO, CA
UEIQ1NZN4P95F83
CAGE code8BMG6
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyVIVID BIOINNOVATIONS, PBC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- San Francisco, California 94107-3007
- Congressional district (place of performance)
- CA-11As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 12
Solicitation and notices
- Solicitation ID
- SBIRPHS20251(as reported)
- Solicitation date
- Aug 2, 2024
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 28, 2025Base obligation at award: $595,337
- Latest action
- Aug 28, 2025 — Base awardModification 0; obligation change +$595,337
- Actions by type
- Base award1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $595,337
- Latest action: change in base and all options
- $2,566,049
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Research program (SBIR/STTR)
- Small business innovation research program phase i actionSR1
- Walsh-Healey Act (materials and supplies)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 1
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2025/2025-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression